{{multiple issues|
{{inappropriate tone|time=2014-06-10T08:21:35+00:00}}
{{newsrelease|time=2014-06-10T08:21:35+00:00}}
{{orphan|time=2016-04-24T18:21:05+00:00}}
}}
{{Infobox scientist
| birth_date       = {{birth date and age|1938|9|9|df=yes}}
| birth_place      = {{TWN-JPN}}[[新竹州|新竹州]]
| nationality      = {{ROC}}
| field       = [[理論生物學|理論生物學]]、[[藥理學|藥理學]]、{{le|癌症研究|Cancer Research}}<ref>[http://www.researcherid.com/rid/B-4111-2009, by Thomson Reuters Web of Science for "Ting-Chao_Chou"]{{Dead link|date=2019年11月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>
| work_institution = [[耶魯大學|耶魯大學]]<br>[[约翰霍普金斯大学|约翰霍普金斯大学]]<br>[[康奈爾大學|康奈爾大學]]
[[斯隆凯特琳癌症中心|斯隆凯特琳癌症中心]]
（2013年6月1日退休）
| known_for   = 
* Median-effect Equation, the Unified Theory of the Mass-Action Law
* Combination Index {CI} defines Synergism (CI<1), Additive Effect (CI=1) and Antagonism (CI>1) with computerized simulations using Compusyn or CalcuSyn		
* Dose Reduction Index (DRI), Normalized Isobologram, and Polygonogram
* Econo-Green Bio-research and Development
* Quantitative Bio-Informatics
* Fludelone, Iso-oxazole-Fludelone, Panaxytriols, Ardeemins
* Illustration of Ancient Chinese Philosophy with Modern Sciences
}}
'''周廷潮'''（{{lang-en|Ting-Chao Chou}}，{{bd|1938年|9月9日}}）美籍华裔[[理论生物学|理论生物学]]家，[[癌症|癌症]]药物学家。[[耶鲁大学|耶鲁大学]]<ref name="耶鲁大学">{{Cite web |url=http://pkunews.pku.edu.cn/zdlm/2008-10/21/content_130609.htm |title=耶鲁大学博士周廷潮教授北大谈古论今 |access-date=2014-03-28 |archive-url=https://web.archive.org/web/20140328121606/http://pkunews.pku.edu.cn/zdlm/2008-10/21/content_130609.htm |archive-date=2014-03-28 |dead-url=yes }}</ref>博士，曾任[[康奈尔大学|康奈尔大学]]教授及[[纽约|纽约]]{{link-en|斯隆凯特琳癌症中心|Memorial Sloan-Kettering Cancer Center}}<ref name="ncic">{{Cite web |url=http://prof.ncic.ac.cn/person/190364 |title=周廷潮，国家智能计算机研究开发中心 |accessdate=2014-03-28 |archive-date=2014-03-28 |archive-url=https://web.archive.org/web/20140328114347/http://prof.ncic.ac.cn/person/190364 |dead-url=yes }}</ref>临床前药理主任，也是[[中国医学科学院|中国医学科学院]]名誉教授。發表數百篇論文，[[H指數|H指數]]為67<REF>
{{Cite web |url=https://scholar.google.de/citations?user=xjcodA8AAAAJ&hl=en |title=Google Scholar Ting-Chao Chou |accessdate=2016-05-04 |archive-date=2019-08-03 |archive-url=https://web.archive.org/web/20190803010214/https://scholar.google.de/citations?user=xjcodA8AAAAJ&hl=en |dead-url=no }}
</ref>。

==生平及事迹==
周廷潮1938年9月9日出生於[[台灣日治时期|台灣日治时期]]的[[新竹郡|新竹郡]][[湖口庄|湖口庄]]長岡嶺。[[新竹中学|新竹中学]]及[[高雄医学院|高雄医学院]]药学系毕业，[[台湾大学|台湾大学]]医学院硕士，[[耶鲁大学|耶鲁大学]]博士。在[[约翰霍普金斯大学|约翰霍普金斯大学]]医学院师從药理主任{{le|保羅·塔拉雷|Paul Talalay}}教授/院士從事博士后研究。于1972年受聘于斯隆凯特琳癌症中心及康乃尔大学医学研究院担任教职，于1988年升任教授。

周廷潮曾任[[中国医学科学院|中国医学科学院]]名誉教授，[[南京医科大学|南京医科大学]]、[[同济医科大学|同济医科大学]]客座教授。
周氏「质量作用中效定理」<ref name="The median-effect equation">{{Cite web |url=http://www.sciencedirect.com/science/article/pii/0022519376901697 |title=Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands |accessdate=2016-05-04 |archive-date=2018-12-11 |archive-url=https://web.archive.org/web/20181211015829/https://www.sciencedirect.com/science/article/pii/0022519376901697 |dead-url=no }}</ref>，于1976年提出，已发展成普世通用定理（The Median-Effect Equation As the Unified Theory）。周塔氏「药物合并指数定理」（The Combination Index Theorem）于1984年提出<ref name="Chou_Talalay"/>。周氏与科研伙伴擁有39个美国专利。与丹尼雪夫斯基教授发明了依波西隆抗癌化合物，以及從高丽参主成分改造研发的细胞保护剂，大量减低化疗及放射疗法所产生的毒性。

周氏理论另有二项主要进展，一是应用于高效益绿色医药研发<ref name="医药研发">{{Cite web |url=http://www.biosino.org/news-2001/200107/01070604.htm |title=华裔专家研发抗癌新药 对八种癌症极为有效 |accessdate=2014-03-28 |archive-date=2014-03-29 |archive-url=https://web.archive.org/web/20140329215729/http://www.biosino.org/news-2001/200107/01070604.htm |dead-url=yes }}</ref>（Econo-Green Bio-Research and Development)及电脑自动化演析。另一是提出中国古代哲学的现代数理新义诠释，已发表于四个国际哲学会議（包括2007年的美国哲学会东区年会及2008年的世界哲学大会<ref>{{Cite web |url=http://www.pdcnet.org/wcp22/content/wcp22_2008_0002_0021_0039 |title=A New Look at the Ancient Asian Philosophy through Modern Mathematical and Topological Scientific Analysis World Congress of Philosophy, 2008, Seoul |accessdate=2014-03-27 |archive-date=2019-10-30 |archive-url=https://web.archive.org/web/20191030152618/https://www.pdcnet.org/wcp22/content/wcp22_2008_0002_0021_0039 |dead-url=no }}</ref>），也曾在北京大學等地發表演講<ref>{{Cite web |url=http://pkunews.pku.edu.cn/zdlm/2008-10/21/content_130609.htm |title=Peking University Speech, 10/24/2008 |access-date=2014-03-28 |archive-url=https://web.archive.org/web/20140328121606/http://pkunews.pku.edu.cn/zdlm/2008-10/21/content_130609.htm |archive-date=2014-03-28 |dead-url=yes }}</ref>。

==科学研究及创作==
周廷潮发表數百篇著作，其中理论及实验约各半。收录入{{le|Web of Science|Web Of Science}} 及[[Google学术搜索|Google学术搜索]]。包括原著、评论、前瞻、美国专利、学术会议论文摘要及电脑软件等。
===质量作用中效定理===
质量作用中效定理（Median-Effect Principle）是周廷潮1976年正式提出的定理<ref name="The median-effect equation"/>，以物理及化学质量作用原理为模型及[[酵素动力学|酵素动力学]]做系统分析，再以数学演绎归纳为方案下所提出的：

<math>\frac{fa}{fu} = \left ( \frac{D}{Dm} \right )^m</math>

其中致效（Fa）与不致效（Fu）之比例等于[[剂量|剂量]]（D）与中效剂量（Dm）之比例的m次方。Dm为剂量作用之中效强度指标；m=1为[[抛物线|抛物线]]，m>1为S型双曲线，而m<1为扁双曲线。

符合物理、化学质量作用原理的任何剂效图形，可以用周氏剂效图解（The Median-Effect Plot）转换成直线。其斜度即为m值，而X轴交切点即为<math>log(Dm)</math> 值。在取得剂效资料后，可以用电脑软件CompuSyn<ref>{{Cite web |url=http://www.combosyn.com/ |title=CompuSyn Software by Chou & Martin, 2005, Combosyn, Inc., Paramus, NJ. Free download.  2012- |accessdate=2016-05-01 |archive-date=2020-12-01 |archive-url=https://web.archive.org/web/20201201044957/http://www.combosyn.com/ |dead-url=no }}</ref>或CalcuSyn<ref>{{Cite web |url=http://www.biosoft.com/w/calcusyn.htm |title=CalcuSyn Software by Chou & Hayball, 1998,  Biosoft, Cambridge, UK |accessdate=2014-03-27 |archive-date=2020-06-16 |archive-url=https://web.archive.org/web/20200616164133/http://biosoft.com/w/calcusyn.htm |dead-url=no }}</ref> 演算m及Dm值，并且显示出剂效电脑拟模图形。

周氏进一步证明；中效质量（Dm）是普世联接点及指标点，不管是单一物质（n=1）或是复方物质（n>1）；不管是一级动力学层次（m=1）或是高等动力学层次（m≠1）皆能通用。此为剂效关系最精简的表达，也是[[酵素动力学|酵素动力学]]的[[米氏動力學|米氏動力學]]，[[阿奇博爾德·希爾|阿奇博爾德·希爾]]的高动力学层次常数公式，有關氫離子解離的[[亨德森－哈塞爾巴爾赫方程|亨德森－哈塞爾巴爾赫方程]]，以及Scatchard的受体分离常数公式的共同表述{{fact}}。

===药物合并指数定理===
药物合并指数定理（The Combination Index Theorem）及电脑解析是1984年由周廷潮及塔氏（Talalay）提出的定理，是从单一物质到复方物质的系统推广<ref name="Chou_Talalay">{{cite journal | url=http://www.sciencedirect.com/science/article/pii/0065257184900074 | title=Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors | author=Ting-Chao Chou, Paul Talalay | journal=Advances in Enzyme Regulation | year=1984 | volume=22 | pages=27-55 | doi=10.1016/0065-2571(84)90007-4 | access-date=2016-05-04 | archive-date=2018-12-11 | archive-url=https://web.archive.org/web/20181211100411/https://www.sciencedirect.com/science/article/pii/0065257184900074 }}</ref>。合并指数（CI）可以定量[[协同作用|协同作用]]（CI<1），相加作用（CI=1），及[[拮抗作用|拮抗作用]]（CI>1）。其二药合并之公式为:
:<math>CI=\frac{(D)_1}{(D_x)_1}+\frac{(D)_2}{(D_x)_2}=\frac{(D)_1}{(D_m)_1[f_a/(1-f_a)]^{1/m_1} }+\frac{(D)_2}{(D_m)_2[f_a/(1-f_a)]^{1/m_2} }</math>
其中
:<math>(D_x)_1</math>是<math>(D)_1</math>单独时抑制x% 之剂量
:<math>(D_x)_2</math>是<math>(D)_2</math>单独时抑制x% 之剂量。

而在二项之分子上<math>(D)_1</math>+<math>(D)_2</math>合并时也抑制x% 之剂量，而fa、m、Dm之定义如上节所示。

使用CompuSyn电脑软件输入各单药及其合并在各剂量之效用（fa值），则fa-CI图形（Chou-Talalay Plot）自动扫描测定药物之协同或拮抗作用。此方法给予研究机构，药检局，制药厂及专利局制定药物合并事项提供严格定量标准。三个以上药物之合并理论已落实，亦可自动化解析。癌症治疗常用多种药物，治疗爱滋病多用[[鸡尾酒疗法|鸡尾酒疗法]]，中医多用复方，這些的现代化定量解析可以應用CI方法及其程式進行。

===高效益绿色医药研发===
高效益绿色医药研发是以上述定理為基礎的医药研发。剂效图形可以转换成直线的论述，导致观念上的基本突破。此即至少两点数据（精简资料），则可电脑拟模全程剂效曲线（Two Points Minimum for Dose-Effect Curve）。用此定理可由少数资料点，去配对“自然法则”（质量作用定理）。如此可以進行小型实验、少数据、少时间、少用动物、少用病人于临床实验的[[绿色医药研发|绿色医药研发]]<ref>{{Cite web |url=http://blogs.rsc.org/ib/2011/05/05/hot-one-equation-to-lead-the-way-to-greener-biomedical-sciences/ |title=HOT: one equation to lead the way to greener biomedical sciences |access-date=2014-03-27 |archive-url=https://web.archive.org/web/20160304023110/http://blogs.rsc.org/ib/2011/05/05/hot-one-equation-to-lead-the-way-to-greener-biomedical-sciences/ |archive-date=2016-03-04 |dead-url=yes }}</ref><ref>{{Cite web |url=http://jnci.oxfordjournals.org/content/86/20/1517 |title=Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol Design |access-date=2014-03-27 |archive-date=2016-03-26 |archive-url=https://web.archive.org/web/20160326150538/http://jnci.oxfordjournals.org/content/86/20/1517 }}</ref><ref>{{Cite web |url=http://cancerres.aacrjournals.org/content/70/2/440.full |title=Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method |accessdate=2014-03-27 |archive-date=2013-02-27 |archive-url=https://web.archive.org/web/20130227092124/http://cancerres.aacrjournals.org/content/70/2/440.full |dead-url=no }}</ref><ref>{{Cite web |url=http://www.bio-itworldexpoeurope.com/bio-it_europe_content.aspx?id=106874&libID=106831 |title=Drug Discovery Informatics |accessdate=2014-03-27 |archive-date=2011-11-21 |archive-url=https://web.archive.org/web/20111121022654/http://www.bio-itworldexpoeurope.com/Bio-It_Europe_Content.aspx?id=106874&libID=106831 |dead-url=no }}</ref><ref>{{Cite web |url=http://www.worldcat.org/title/dose-effect-analysis-with-microcomputers/oclc/20772177 |title=Dose-effect analysis with microcomputers |accessdate=2016-04-24 |archive-date=2019-10-19 |archive-url=https://web.archive.org/web/20191019090641/https://www.worldcat.org/title/dose-effect-analysis-with-microcomputers/oclc/20772177 |dead-url=no }}</ref>
<ref>{{Cite web |url=http://dspace.mit.edu/handle/1721.1/90152 |title=Computational analysis of biochemical networks for drug target identification and therapeutic intervention design |accessdate=2016-04-24 |archive-date=2019-10-14 |archive-url=https://web.archive.org/web/20191014004259/https://dspace.mit.edu/handle/1721.1/90152 |dead-url=no }}</ref>

==专利发明==
周氏发明以抗细胞微管为标的的{{link-en|依波西隆|Epothilone}}[[抗癌|抗癌]]化合物，以及以DNA[[烷化剂|烷化剂]]为标的抗癌药物。此外有抗排斥之器官移植免疫抑制剂，以及從高丽参主成分化学改造合成的高丽参精三醇化合物{{le|Panaxytriols|Panaxytriols}}，用于细胞保护以及减少[[化学疗法|化学疗法]]及[[放射治疗|放射治疗]]所产生的毒性及副作用<ref>{{Cite web |url=http://patentscope.wipo.int/search/en/WO2008103916 |title=Panaxytriols Patent |accessdate=2014-03-27 |archive-date=2013-10-22 |archive-url=https://web.archive.org/web/20131022130219/http://patentscope.wipo.int/search/en/WO2008103916 |dead-url=no }}</ref><ref>{{Cite web |url=http://www.pnas.org/content/108/34/14336.full.pdf+html |title=Panaxytriols, PNAS Article, 2011 |accessdate=2014-03-27 |archive-date=2015-09-24 |archive-url=https://web.archive.org/web/20150924155332/http://www.pnas.org/content/108/34/14336.full.pdf+html |dead-url=no }}</ref><ref>{{Cite web |url=http://www.pnas.org/content/suppl/2011/08/09/1111332108.DCSupplemental/pnas.201111332SI.pdf |title=Panaxytriols, PNAS Supplements |access-date=2014-03-27 |archive-date=2019-10-20 |archive-url=https://web.archive.org/web/20191020094404/https://www.pnas.org/content/suppl/2011/08/09/1111332108.DCSupplemental/pnas.201111332SI.pdf }}</ref><ref>{{Cite web |url=http://cancerres.aacrjournals.org/content/65/20/9445 |title=Fludelone, Cancer Research Article 2005 |accessdate=2014-03-27 |archive-date=2017-09-10 |archive-url=https://web.archive.org/web/20170910211815/http://cancerres.aacrjournals.org/content/65/20/9445 |dead-url=no }}</ref><ref>{{Cite web |url=http://www.pnas.org/content/105/35/13157.full.pdf+html |title=Iso-oxazole-fludelone PNAS Article, 2008 |access-date=2014-03-27 |archive-date=2015-09-24 |archive-url=https://web.archive.org/web/20150924145918/http://www.pnas.org/content/105/35/13157.full.pdf+html }}</ref>，周廷潮與科研夥伴共同擁有美国专利共计39项<ref>{{Cite web |url=http://patent.ipexl.com/inventor/Ting-Chao_Chou_1.html |title=US Patents Full Listing |access-date=2014-03-27 |archive-url=https://web.archive.org/web/20160306103812/http://patent.ipexl.com/inventor/Ting-Chao_Chou_1.html |archive-date=2016-03-06 |dead-url=yes }}</ref><ref>{{Cite web |url=http://patents.justia.com/search?q=Ting-Chao+Chou&page=3 |title=US Patents Listing |access-date=2014-03-27 |archive-date=2019-11-09 |archive-url=https://web.archive.org/web/20191109134222/https://patents.justia.com/search?q=Ting-Chao+Chou&page=3 }}</ref><ref>{{Cite web |url=http://radaris.com/p/Ting-Chao/Chou/ |title=US Patents Partial Listing |accessdate=2014-03-27 |archive-date=2019-10-18 |archive-url=https://web.archive.org/web/20191018163332/https://radaris.com/p/Ting-Chao/Chou/ |dead-url=no }}</ref><ref>{{Cite web |url=http://www.faqs.org/patents/inventor/ting-chao-chou-paramus-us-1/ |title=US Patents Statistics |accessdate=2014-03-27 |archive-date=2016-03-04 |archive-url=https://web.archive.org/web/20160304073906/http://www.faqs.org/patents/inventor/ting-chao-chou-paramus-us-1/ |dead-url=no }}</ref>。

==著作==
1.  The Unified Theory
* http://pharmrev.aspetjournals.org/cgi/reprint/58/3/621{{Wayback|url=http://pharmrev.aspetjournals.org/cgi/reprint/58/3/621 |date=20090409115116 }}  [The 61-page Pharmacological Reviews Article for the Median-Effect Equation and the Combination Index theorem]   (Cited 1,446 times in 440  bio-medical journals between 2007–1/19/2016)
* http://www.cell.com/trends/pharmacological-sciences/abstract/0165-6147(83)90490-X{{Wayback|url=http://www.cell.com/trends/pharmacological-sciences/abstract/0165-6147(83)90490-X |date=20131017065901 }}    [A New Look at A Very Old Problem] (Cited 382  times)  
* http://cancerres.aacrjournals.org/content/70/2/440.full{{Wayback|url=http://cancerres.aacrjournals.org/content/70/2/440.full |date=20130227092124 }}   [Perspective Article, 2010 ]   (Cited 828 times in 237 journals)  
* http://www.sciencedirect.com/science/article/pii/0022519372900409{{Wayback|url=http://www.sciencedirect.com/science/article/pii/0022519372900409 |date=20181211004407 }} [Combinatory Analysis, J Theor Biol 1972]  
* http://www.jbc.org/content/252/18/6438.full.pdf{{Wayback|url=http://www.jbc.org/content/252/18/6438.full.pdf |date=20200125142737 }} [Theoretical Development] (Cited 201 times) (Chou - Talalay Theory, 1977).
* http://www.zoominfo.com/p/Ting-Chao-Chou/1326248255   [FEBS article 1981]
* http://onlinelibrary.wiley.com/doi/10.1111/j.1432-1033.1981.tb06218.x/full{{Wayback|url=http://onlinelibrary.wiley.com/doi/10.1111/j.1432-1033.1981.tb06218.x/full |date=20170319055921 }}    [Basic Theory, 1981 FEBS]
* https://archive.is/20160424021210/http://libra.msra.cn/Publication/35878781/analysis-of-combined-drug-effects-a-new-look-at-a-very-old-problem   [TIPS Trend Article, 1983]
* http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196289/   [AJCR review article, 2011]
* http://www.tandfonline.com/doi/abs/10.1080/10428190802353591?journalCode=ilal20      [Leukemia & Lymphoma clinical  review article, 2008] 
* https://web.archive.org/web/20141226071743/http://omicsonline.org/1948-5964/1948-5964.S1.1-5.pdf   [Virology-2011 Published in Antivir Antiretrovir, vol 3 issue 4-6]   (Keynote Speech) 
* http://www.nature.com/nm/journal/v6/n2/full/nm0200_200.html {{Wayback|url=http://www.nature.com/nm/journal/v6/n2/full/nm0200_200.html |date=20051204065734 }}   [Nature Medicine 6:200-206, 2000]    [Cited 844 times as of 1/19/2016]
* http://www.amazon.com/books/dp/0121740900   [Book, Academic Press, 1991] 
* http://www.sciencedirect.com/science/article/pii/S2213713014000042 {{Wayback|url=http://www.sciencedirect.com/science/article/pii/S2213713014000042 |date=20181211061040 }}  [Synergy journal inaugural article by Chou, 2014]
* https://web.archive.org/web/20160306094848/http://regulatoryaffairs.pharmaceuticalconferences.com/speaker/2015/ting-chao-chou-pd-science-llc-usa   [Pharmaceutical Regulatory Affairs -Keynote Speech, Orlando, FL  Aug..3  2015]
* http://scholar.google.com/scholar?start=0&q=%22author:Chou+author:Ting-Chao.%22&hl=en&as_sdt=0,31              [Chou TC, 341 Publications & Their Citations]

==參考資料==
{{reflist}}
==外部链接==
*[http://precedings.nature.com/documents/2064/version/2 T.C. Chou, The Mass-Action Law for Bio-Informatics. Nature Precedings,  7/22/2008] {{Wayback|url=http://precedings.nature.com/documents/2064/version/2 |date=20200122183941 }}
*[http://blogs.rsc.org/ib/2011/05/05/hot-one-equation-to-lead-the-way-to-greener- biomedical-sciences Integrative  Biology Blog. by Francesca Burgoyne with Comments. 5.5.2011]{{Dead link|date=2019年10月 |bot=InternetArchiveBot |fix-attempted=yes }}.
*[http://laoyouji000.blog.sohu.com/102704065.html Comments on Chou's Speech in Beijing by Muyu in Sohu Blog, in Chinese]{{Wayback|url=http://laoyouji000.blog.sohu.com/102704065.html |date=20181008014946 }}
*[http://libgallery.cshl.edu/items/show/32731 Chou's letter to Prof. James D. Watson. 10/6/1974, Cold Spring Harbor Laboratory Archives Repository] {{Wayback|url=http://libgallery.cshl.edu/items/show/32731 |date=20181003232447 }}
*[http://tingchaochou.blogspot.com/ 周廷潮的部落格]{{Wayback|url=http://tingchaochou.blogspot.com/ |date=20190804174123 }}
*[https://web.archive.org/web/20160810040132/http://www.worldjournal.com/3369299/ 《人物》科學家周廷潮 理論引用世界第一 | 世界新聞網 ]

{{DEFAULTSORT: Chou, Ting-Chao}}
[[Category:台灣生物學家|Category:台灣生物學家]]
[[Category:约翰斯·霍普金斯大学校友|Category:约翰斯·霍普金斯大学校友]]
[[Category:耶魯大學校友|Category:耶魯大學校友]]
[[Category:國立臺灣大學醫學院校友|Category:國立臺灣大學醫學院校友]]
[[Category:高雄醫學院校友|Category:高雄醫學院校友]]
[[Category:國立新竹高級中學校友|Category:國立新竹高級中學校友]]
[[Category:湖口人|Category:湖口人]]
[[Category:周姓|Category:周姓]]